Tapewire

NYSE · USD

AORT

ARTIVION, INC.

Export transactions ↓
Tapewire entity
4767
SEC CIK
0000784199
Parsed reports
700

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025024
Dec 202506
Jan 202600
Feb 2026012
Mar 2026013
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202604
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2024 Filed Mar 15, 2024 00:36 UTC Amendment
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 10,644 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 3

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,157

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:36 UTC Amendment
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 5,386 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,089

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:33 UTC Amendment GrantCommon Stock 6,418 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 3

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,632

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:33 UTC Amendment GrantCommon Stock 3,366 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 1

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,382

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:31 UTC Amendment
Holloway Jean FSVP, General Counsel
GrantCommon Stock 12,836 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,395

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:31 UTC Amendment
Holloway Jean FSVP, General Counsel
GrantCommon Stock 5,386 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,854

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:29 UTC Amendment
GREEN ANDREW MVP Regulatory
GrantCommon Stock 6,914 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 3

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,779

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:29 UTC Amendment
GREEN ANDREW MVP Regulatory
GrantCommon Stock 3,366 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,033

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment
Davis John EChief Commercial Officer
GrantCommon Stock 12,736 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 3

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,447

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment
Davis John EChief Commercial Officer
GrantCommon Stock 5,386 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,279

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:14 UTC Amendment
Mackin James PPresident & CEO
GrantCommon Stock 58,648 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 3

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 709,221

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:14 UTC Amendment
Mackin James PPresident & CEO
GrantCommon Stock 40,404 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668,441

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:04 UTC Amendment
Getz Matthew AVP, Human Resources
GrantCommon Stock 7,412 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 3

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,552

F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Read SEC document
February 23, 2024 Filed Mar 15, 2024 00:04 UTC Amendment
Getz Matthew AVP, Human Resources
GrantCommon Stock 3,366 $0.00 $0.00
Disclosure

SEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,308

F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:37 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 1,192 $18.87 $22,487.08
Disclosure

SEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,858

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:37 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 464 $18.87 $8,753.36
Disclosure

SEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,050

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:37 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 1,871 $18.87 $35,296.42
Disclosure

SEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,514

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:35 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 366 $18.87 $6,904.59
Disclosure

SEC source: 0000784199-24-000026 · wk-form4_1708641295.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,345

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:35 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 1,329 $18.87 $25,071.59
Disclosure

SEC source: 0000784199-24-000026 · wk-form4_1708641295.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,711

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:32 UTC
Davis John EChief Commercial Officer
SaleCommon Stock 496 $18.87 $9,357.04
Disclosure

SEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,177

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:32 UTC
Davis John EChief Commercial Officer
SaleCommon Stock 2,060 $18.87 $38,861.90
Disclosure

SEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,673

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:29 UTC SaleCommon Stock 407 $18.87 $7,678.06
Disclosure

SEC source: 0000784199-24-000022 · wk-form4_1708640975.xml · nonDerivative · entry 1

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,123

F1 · shares: These shares were sold upon the vesting of Restricted Stock to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:26 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 366 $18.87 $6,904.59
Disclosure

SEC source: 0000784199-24-000020 · wk-form4_1708640771.xml · nonDerivative · entry 2

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,692

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:26 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 1,329 $18.87 $25,071.59
Disclosure

SEC source: 0000784199-24-000020 · wk-form4_1708640771.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,058

F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:22 UTC
Tyrs FlorianVP, Global Operations
SaleCommon Stock 249 $18.87 $4,697.39
Disclosure

SEC source: 0000784199-24-000018 · wk-form4_1708640525.xml · nonDerivative · entry 1

Tyrs Florian · CIK 0001983377 · VP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,253

F1 · shares: These shares were sold upon the vesting of Restricted Stock to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:08 UTC
Mackin James PPresident & CEO
Exercise / conversionStock Option(Right to Buy) · Derivative 59,225 $0.00 Strike: $16.30 $0.00
Disclosure

SEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · derivative · entry 5

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,225 shares

Expires 2024-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:08 UTC
Mackin James PPresident & CEO
SaleCommon Stock 2,756 $18.87 $51,991.94
Disclosure

SEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 4

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 539,036

F4 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:08 UTC
Mackin James PPresident & CEO
SaleCommon Stock 10,088 $18.87 $190,310.12
Disclosure

SEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 3

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 541,792

F3 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:08 UTC
Mackin James PPresident & CEO
SaleCommon Stock 59,225 $18.85 $1,116,515.62
Disclosure

SEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 2

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 551,880

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023.

F2 · price: Reflects weighted average price. Range of prices were between $18.05 to $19.295. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:08 UTC
Mackin James PPresident & CEO
Exercise / conversionCommon Stock 59,225 $16.30 $965,367.50
Disclosure

SEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 611,105

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:25 UTC
Holloway Jean FSVP, General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 21,229 $16.30 Strike: $16.30 $346,032.70
Disclosure

SEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · derivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,229 shares

Expires 2024-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:25 UTC
Holloway Jean FSVP, General Counsel
SaleCommon Stock 21,229 $18.00 $382,122.00
Disclosure

SEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,520

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023.

F2 · price: Reflects the price the shares were sold.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:25 UTC
Holloway Jean FSVP, General Counsel
Exercise / conversionCommon Stock 21,229 $16.30 $346,032.70
Disclosure

SEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:22 UTC
Davis John ESenior VP, Global Sales
Exercise / conversionStock Option (Right to Buy) · Derivative 13,562 $16.30 Strike: $16.30 $221,060.60
Disclosure

SEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · derivative · entry 3

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,562 shares

Expires 2024-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:22 UTC
Davis John ESenior VP, Global Sales
SaleCommon Stock 13,562 $18.00 $244,116.00
Disclosure

SEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,733

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023.

F2 · price: Reflects the price the shares were sold.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:22 UTC
Davis John ESenior VP, Global Sales
Exercise / conversionCommon Stock 13,562 $16.30 $221,060.60
Disclosure

SEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023.

Read SEC document
December 31, 2023 Filed Jan 31, 2024 01:09 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 472 $14.61 $6,896.63
Disclosure

SEC source: 0000784199-24-000008 · wk-form5_1706663381.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,385

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
December 31, 2023 Filed Jan 31, 2024 01:00 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 565 $14.61 $8,255.50
Disclosure

SEC source: 0000784199-24-000006 · wk-form5_1706662850.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,903

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:23 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 14,397 $16.30 Strike: $16.30 $234,671.10
Disclosure

SEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · derivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,397 shares

Expires 2024-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:23 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 14,397 $19.00 $273,543.00
Disclosure

SEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,040

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023.

F2 · price: Reflects the price the shares were sold.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 22:23 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionCommon Stock 14,397 $16.30 $234,671.10
Disclosure

SEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 14:16 UTC
Berry Lance AExecutive VP, CFO
GrantStock Option (Right to Buy) · Derivative 93,633 $0.00 Strike: $17.83 $0.00
Disclosure

SEC source: 0000784199-23-000161 · wk-form4_1702044996.xml · derivative · entry 2

Berry Lance A · CIK 0001478716 · Executive VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,633

Underlying: Common Stock · 93,633 shares

Expires 2030-12-06

F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 14:16 UTC
Berry Lance AExecutive VP, CFO
GrantCommon Stock 42,064 $17.83 $750,001.12
Disclosure

SEC source: 0000784199-23-000161 · wk-form4_1702044996.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · Executive VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,064

F1 · balance_after: Represents shares of restricted stock that vest on the third anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
December 06, 2023 Filed Dec 8, 2023 14:09 UTC
Horton AmyVP, Chief Accounting Officer
GrantCommon Stock 20,191 $17.83 $360,005.53
Disclosure

SEC source: 0000784199-23-000157 · wk-form4_1702044554.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,040

F1 · balance_after: Represents shares of restricted stock 50% vests on the first anniversary and 50% vests on the second anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 14:15 UTC
Horton AmyVP, Chief Accounting Officer
GiftCommon Stock 1,750 $17.51 $30,642.50
Disclosure

SEC source: 0000784199-23-000152 · wk-form4_1701267350.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,849

F2 · shares: 1,750 shares were gifted by the reporting person to a charity.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 14:15 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 2,101 $17.34 $36,431.34
Disclosure

SEC source: 0000784199-23-000152 · wk-form4_1701267350.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,599

F1 · price: Reflects the price the shares were sold.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 12:48 UTC
Tyrs FlorianVP, Global Operations
GrantStock Option (Right to Buy) · Derivative 4,699 $0.00 Strike: $16.79 $0.00
Disclosure

SEC source: 0000784199-23-000141 · wk-form4_1691671730.xml · derivative · entry 3

Tyrs Florian · CIK 0001983377 · VP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,699

Underlying: Common Stock · 4,699 shares

Expires 2030-08-08

F2 · derivative.expiration_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date

Read SEC document
August 08, 2023 Filed Aug 10, 2023 12:48 UTC
Tyrs FlorianVP, Global Operations
GrantCommon Stock 2,107 $16.79 $35,376.53
Disclosure

SEC source: 0000784199-23-000141 · wk-form4_1691671730.xml · nonDerivative · entry 1

Tyrs Florian · CIK 0001983377 · VP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,502

F1 · balance_after: Represents shares of restricted stock that vest on the third anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Read SEC document
June 30, 2023 Filed Jan 31, 2024 01:12 UTC
Davis John ESenior VP, Global Sales
GrantCommon Stock 2,000 $10.30 $20,604.00
Disclosure

SEC source: 0000784199-24-000010 · wk-form5_1706663520.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,733

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document
June 30, 2023 Filed Jan 31, 2024 01:09 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 1,393 $10.30 $14,350.69
Disclosure

SEC source: 0000784199-24-000008 · wk-form5_1706663381.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,913

F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.